07.08.2018 • NewsBioAmberElaine Burridge

BioAmber Seeks to Liquidate Assets

BioAmber Seeks to Liquidate Assets (c) Erce/Shutterstock
BioAmber Seeks to Liquidate Assets (c) Erce/Shutterstock

Having received no acceptable offers for its business by a Jul. 27 deadline, Canadian renewable chemicals company BioAmber is now seeking court approval to liquidate its assets, which include a commercial scale succinic acid plant in Sarnia, Ontario, Canada.

The company filed for bankruptcy protection in the US and Canada in May.

“We are clearly disappointed that the qualified bidders did not place an acceptable offer for BioAmber,” said CEO Richard Eno. “We will continue to be actively engaged with potential investors to seek an acceptable transaction and avoid the liquidation of the company’s assets.” The company has until Aug. 14 to conclude a transaction.

Last year, two class action lawsuits were filed in the US against BioAmber by investors claiming that the company made false and misleading statements between Dec. 23, 2016 and Mar. 16, 2017. The claimants allege it failed to disclose that an expected $2.8 million sale of succinic acid was postponed from the fourth quarter of 2016 to sometime in 2017, causing the value of their shares to drop once the news became public.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read